Search Ontology:
ChEBI
atrasentan
- Term ID
- CHEBI:135810
- Synonyms
-
- (+)-A 127722
- (+)-A-127722
- (+)-A127722
- (2R, 3R, 4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid
- (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid
- (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid
- A 147627
- A-147627
- ABT 627
- ABT-627
- ABT627
- atrasentan
- atrasentanum
- Definition
- A member of the class of pyrrolidines that is pyrrolidine substituted by 2-(dibutylamino)-2-oxoethyl, 4-methoxyphenyl, carboxy, and 1,3-benzodioxol-5-yl groups at positions 1, 2, 3, and 4, respectively (the 2R,3R,4S-stereoisomer). It is an endothelin endothelin type A receptor antagonist used to reduce proteinuria in adults with primary immunoglobulin A nephropathy.
- References
-
- CAS:173937-91-2
- DrugBank:DB06199
- PMID:10610291
- PMID:11739244
- PMID:12193124
- PMID:17440096
- PMID:19717985
- PMID:25189702
- PMID:28230089
- PMID:30098343
- PMID:30198212
- PMID:30217875
- PMID:31982064
- PMID:31982065
- PMID:31982067
- PMID:32195223
- PMID:34853062
- PMID:34853063
- PMID:35119336
- PMID:35772861
- PMID:35892316
- PMID:37139863
- PMID:37157922
- PMID:37235521
- PMID:37657768
- PMID:37716952
- PMID:37820676
- PMID:37981428
- PMID:38969296
- PMID:39460694
- PMID:39503150
- PMID:39661119
- PMID:39798547
- PMID:39810771
- PMID:40245183
- PMID:40303226
- Wikipedia:Atrasentan
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from atrasentan
Phenotype where environments contain atrasentan
Phenotype modified by environments containing atrasentan
Phenotype affecting atrasentan
Human Disease Model